Development of DC-based vaccine therapy by utilizing exosomes collected from healthy volunteer-derived DCs
Development of DC-based vaccine therapy by utilizing exosomes collected from healthy volunteer-derived DCs
批准号:
18591440
负责人:
MORISAKI Takashi
金额:
$2.39万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007
中文摘要
本研究的目的是开发一种制备树突状细胞(DC)的方法,这种树突状细胞具有在个体之间具有相同的抗原递呈能力,作为癌症患者的治疗工具。利用健康志愿者外周血单个核细胞(PBMC)来源的树突状细胞(DC)分泌的外切体作为研究对象是本研究的独特之处。研究期间获得的数据如下:1)DC来源的外切体的定性和定量评价方法:我们发展了一种结合超速离心法、蔗糖密度法和BDLA-DR结合珠的新方法来提纯和定性定量评价外切体。结果表明,在健康志愿者DC来源的外体上,关键抗原提呈相关分子,包括MHC-II类分子、CD80、CD86和ICAM-1均有高度且均一的表达。另一方面,这些分子在患者来源的DC的外切体上的表达很弱。2)DC来源的Exosome对DC分化和功能的影响:2-1:健康志愿者DC来源的Exosome对CD4T细胞存活的延长。2-2:健康志愿者来源的DC的Exosome促进患者来源DC的分化。2-3提高健康志愿者DC来源的Exosome的NK细胞活性。2-4:从肿瘤细胞冲击的DC收集的Exosome诱导细胞毒性T细胞(CTL)。5):从恶性积液中收集的外切体可延长调节性T细胞的存活时间。3)其他:从CE4基因转染树突状细胞分泌的外切体可能表达CEA。
英文摘要
Aim of this study is to develop a method for preparing dendritic cells (DCs), which have homogeneous ability of antigen presentation between individuals, as therapeutic tool for cancer patients. It is a unique point that exosomes secreted by DCs generated from healthy volunteers' peripheral blood mononuclear cells (PBMCs) are utilized for this ourpose.Data obtained during the research period are as follows:1) Methodology for qualitative and quantitative evaluation of DC-derived exosomes:We developed a new methodology for purification and qualitative and quantitative evaluation of exosomes by combination of ultracentrifugation, sucrose density, and BDLA-DR-bound beads. As a result, it was shown tat critical antigen presentation-related molecules, including MHC class II, CD80, CD86, and ICAM-1, are expressed highly and homogeneously on exosomes derived from healthy volunteer's DCs. On the other hand, expressions of these molecules were weak on exosomes derived from patient-derived DCs.In conclusion, it was strongly indicated that expression of HLA-DR on purified exosomes is a marker for qualitative and quantitative evaluation of DC-derived exosomes.2)Effects of DC"derived exosomes on differentiation and function of DCs:2-1: Survival prolongation of CD4+ T cells by exosomes collected from healty volunteer-derived DCs.2-2: Improved differentiation of patient-derived DCs by exosomes collected from healty volunteerderived DCs.2-3 increased NK cell activity by exosomes collected from healty volunteerderived DCs.2-4: Induction of cytotoxic T cells (CTLs) by exosomes collected from tumor cell-pulsed DCs.2-5: Survival prolongation of regulatory T cells by exosomes collectede from malignant effusions.3)Others:An interesting possibility that exosomes secreted from CE4-transfected DCs express CEA was indicated.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
担癌間者胸腹水中の制御性T細胞(Treg細胞)増加の機序解析
癌症患者胸腹水中调节性T细胞(Treg细胞)增加的机制分析
DOI:
--
发表时间:
2007
期刊:
影响因子:
--
作者:
[和田 純治, ほか]
通讯作者:
ほか
癌患者末梢血中の制御性T細胞(Treg細胞)増加の機序解析と癌免疫療法におけるTreg細胞測定の臨床的意義
癌症患者外周血调节性T细胞(Treg细胞)增加的机制分析及Treg细胞测量在癌症免疫治疗中的临床意义
DOI:
--
发表时间:
2007
期刊:
影响因子:
--
作者:
[和田 純治, ほか]
通讯作者:
ほか
DOI:
10.1007/s00280-006-0219-4
发表时间:
2006-11-01
期刊:
CANCER CHEMOTHERAPY AND PHARMACOLOGY
影响因子:
3
作者:
[Qin, Baoli, Ariyama, Hiroshi, Nakano, Shuji]
通讯作者:
Nakano, Shuji
Regulatory T cells are possible effect prediction markers of immunother apy for cancer patients
调节性T细胞可能是癌症患者免疫治疗效果预测标志物
DOI:
--
发表时间:
期刊:
Anticancer Research (in press)
影响因子:
--
作者:
[Wada J, et. al.]
通讯作者:
et. al.
Regulatory T cells are possible effect prediction markers of immunotherapy for cancer patients
调节性T细胞可能是癌症患者免疫治疗效果预测标志物
DOI:
--
发表时间:
期刊:
Anticancer Research (in press)
影响因子:
--
作者:
[Wada, J, Yamasaki, A, Morisaki, T, Nagai, S, Yanai, K, Fuchino, K, Akiyoshi, T, Koga, K, Nakashima, H, Nakamura, M, Tanaka, M, Katano, M]
通讯作者:
M
Development of new therapeutical strategy for lung NET by inhibiting Hh/Notch signaling targeting RBPJ
-
批准号:18K08788
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.83万
-
财政年份:2018
-
负责人:MORISAKI Takashi
-
依托单位:
The development of the system estimating realtime antitumor activity of activated T lymphocytes in cancer immunotherapy
-
批准号:24591908
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.41万
-
财政年份:2012
-
负责人:MORISAKI Takashi
-
依托单位:
Suppression of induction and accumulation at tumor site of regulatory T cells by inhibition of VEGF/VEGFR2 pathway
-
批准号:21591670
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2009
-
负责人:MORISAKI Takashi
-
依托单位:
Arificial biliary duct model for surgical therapeutic material and research material for biliary cancer
-
批准号:13671245
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.62万
-
财政年份:2001
-
负责人:MORISAKI Takashi
-
依托单位:
Treatment of multiple oragn dysfunction syndrom : establisment of endothelial cell targetting therapy
-
批准号:11671170
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:1999
-
负责人:MORISAKI Takashi
-
依托单位:
Establisment of tumor vaccine using autologous dendritic cells and its application for addaptive immunotherapy
-
批准号:09671321
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.11万
-
财政年份:1997
-
负责人:MORISAKI Takashi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
TMUV-Exosomes调控宿主PKR蛋白磷酸化促进TMUV复制的分子机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2024
-
负责人:梅堃
-
依托单位:
乳腺癌细胞 Exosomes-miR-137 靶向降解巨噬
细胞 DUSP4 从而促进免疫抑制微环境形成的
作用研究
-
批准号:TGY24H160033
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:王淑倩
-
依托单位:
尿液Exosomes中lncRNA表达谱分析在肾结石肾纤维化早期诊断中的应用价值研究
-
批准号:82360157
-
项目类别:地区科学基金项目
-
资助金额:32万元
-
批准年份:2023
-
负责人:陈大进
-
依托单位:
过表达COL7A1的USCs-exosomes@MOFs复合SIS水凝胶治疗隐性营养不良型大疱性表皮松解症的作用研究
-
批准号:82304062
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:周兴丽
-
依托单位:
HucMSC-exosomes阻断HPVE6蛋白介导的IL-10信号通路调节HPV阳性宫颈细胞免疫微环境的生物学功能及分子机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:李田
-
依托单位:
基于调控肿瘤炎性微环境的Hpa/Exosomes/CAFs/IL8&CXCL12&CXCL16途径探讨半枝莲和白花蛇舌草药对抑制三阴性乳腺癌进展的机制研究
-
批准号:82205222
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:马婷婷
-
依托单位:
iMSC-exosomes介导circRNA1063/YBX1/FEZ2复合体促进轴突再生改善神经损伤性ED的机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:陈泽宏
-
依托单位:
hucMSCs-exosomes调节肺泡巨噬细胞有氧糖酵解/脂肪酸氧化平衡减轻肺缺血再灌注损伤
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2022
-
负责人:刘博
-
依托单位:
硅锶掺杂GelMA-PEG微球/EPC-exosomes支架调控心肌常驻巨噬细胞功能分化促进心肌再生
-
批准号:--
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:区彩文
-
依托单位:
蓝氏贾第虫exosomes的鉴定和功能研究
-
批准号:32102699
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:刘静宜
-
依托单位: